←
Deborah Zarin359 posts
Deborah Zarin avatar

Deborah Zarin

@DeborahZarin
◷ Joined March 2020▧ 1 Photos and videos
Allen Frances avatar
⟳ Deborah Zarin retweeted
Allen Frances@AllenFrancesMD·14 Apr 2022

Screening all kids 8-18 for anxiety is dumb/dangerous idea: 1)Causes massive false positive overdiagnosis/stigma/misuse of meds 2)Not enough clinicians to treat kids identified 2)Drains resources better used to improve kid's lives/education 3)Neglects dire needs of severely ill

An influential group of U.S. experts has recommended screening all children ages 8 and older for anxiety, saying the latest research supports early intervention for younger kids. More than 7% of children ages 3 to 17 have diagnosed anxiety, the CDC says. nyti.ms/3EcNA0C

Peter B. Bach, MD avatar
⟳ Deborah Zarin retweeted
Peter B. Bach, MD@peterbachmd·25 Oct 2022

So last week I was at CHEST, a meeting of respiratory docs and < 5% in masks. Now I am at #SMDM22 , a meeting of experts in tradeoffs, spillover effects and social welfare, and 90 pct in masks. I feel like there is a learning here.

Joseph Ross avatar
⟳ Deborah Zarin retweeted
Joseph Ross@jsross119·6 Oct 2022

Seems like a terrible idea. We want Congress to give regulatory agencies the authority to make decisions - esp those that impact public health - using best science/evidence, not to be hamstrung when Congress is unhappy with the decisions. pharmaphorum.com/?p=99430 via @pharmaphorum

Holly Fernandez Lynch avatar
⟳ Deborah Zarin retweeted
Holly Fernandez Lynch@HollyLynchez·1 Oct 2022

3. AMX0035: 1 study, stat sig results re: fxnl decline on co's analysis not FDA's, survival benefit in OLE I get excitement for another option+hope this 1 works. But note this is the assortment of tx options produced by low FDA approval standards. 2/2 accessdata.fda.gov/scripts/c…

David Enrich avatar
⟳ Deborah Zarin retweeted
David Enrich@davidenrich·24 Sep 2022

Today the @nytimes is publishing the first two installments in a series called "Profits Over Patients." It's about how tax-exempt hospitals have strayed from their charitable missions for the sake of fatter profits – with profound consequences for the US healthcare system. 🧵

Post attachment
Deborah Zarin avatar
Deborah Zarin@DeborahZarin·21 Sep 2022

Agree, agree, agree!

Suggesting routine "Anxiety Screening for All Adults Under 65" is dangerously dumb: 1)Astronomical false + rates 2)Triggers even more massive med overuse 3)Impractical in 15 minute 1° care visits 4)Therapists are already in very short supply 5)Neglects great needs of severely ill

Rita Redberg avatar
⟳ Deborah Zarin retweeted
Rita Redberg@RFRedberg·18 Sep 2022

The return on investment to the drug industry of FDA user fees is in billions of dollars. PDUFA is all about how fast can FDA approve drugs, and not about if they help patients. @FDA_Drug_Info F.D.A.’s Drug Industry Fees Fuel Concerns Over Influence nytimes.com/2022/09/15/healt…

Michael P. Hengartner, PhD avatar
⟳ Deborah Zarin retweeted
Michael P. Hengartner, PhD@HengartnerMP·2 Aug 2022

Moreover, the tri-modal distribution found in this analysis was based on an exploratory analysis. Moreover, this analysis was not able to determine which patients can expect a meaningful drug effect and which not. Thus, we still don't know who this 15% of users are